Skip To Main Content
Shangui Liu on Muck Rack

Shangui Liu

As seen in: Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shangui

Contact Shangui, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance Click to copy article link Article link copied!

|
By Shangui Liu, Cheng Zhang, Qixiang Feng
| dx.doi.org
Open in Who Shared Issue with article?

An Atorvastatin/Ferrostatin-1 Codelivered Hybrid Exosome/Liposome System for Combinational Ferroptosis Inhibition, Inflammation Suppression, Efferocytosis Promotion, and Macrophage Reprogramming in Atherosclerosis Treatment

|
By He Zhou, Shangui Liu, Qixiang Feng, Shuangxu Jia
| dx.doi.org
Biological and Medical Applications of Materials and InterfacesJune 12, 2025 Qixiang Feng Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese, Shandong Key Laboratory of Targeted Drug Delivery and Advanced Pharmaceutics, NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine,...
Open in Who Shared Issue with article?

A dual-sensitive nanoparticle-mediated deepening synergistic therapy strategy involving DNA damage and ICD stimuli to treat triple-negative breast cancer

|
By Shangui Liu, Xinru Kong, Yuelin Fang, Zhijing He
| Royal Society of Chemistry Verified
A dual-sensitive nanoparticle-mediated deepening synergistic therapy strategy involving DNA damage and ICD stimuli to treat triple-negative breast cancer Shangui Liu, Xinru Kong, Yuelin Fang, Zhijing He, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye and Guangxi Zhai Abstract Triple-negative breast cancer (TNBC) is one of the most aggressive cancers with an immunosuppressive microenvironment, and achieving a satisfactory effect from monotherapies, such as chemotherapy, photodynamic therapy (PDT) or...
Open in Who Shared Issue with article?
See all 3 articles